Answers are grounded in this paper and cite their sources.
Case report highlights associations between early-onset CPPD and genetic hypomagnesemia, suggesting further evaluation of young patients.
We read with great interest the recent article by Mao et al published in The Journal of Rheumatology describing early-onset calcium pyrophosphate disease (CPPD) associated with genetic hypomagnesemia.¹ The authors emphasized the importance of investigating secondary causes in young patients with CPPD, as well as the role of hypomagnesemia in treatment-resistant disease.
No takes yet. Share an insight, caveat, or question.
Brikman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: